DNA mismatch repair protein immunohistochemistry - an illustrated guide

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• DNA mismatch repair (MMR) corrects DNA replication errors, preventing mutations.
• Deficient MMR (dMMR) elevates tumor mutational burden and neoplasia risk.
• MMR protein assessment is crucial for inherited cancer syndromes like Lynch syndrome.

Purpose of the Study:

• To provide a practical guide for interpreting DNA MMR immunohistochemistry.
• To illustrate the clinical utility of MMR protein assessment in various scenarios.
• To enhance understanding of dMMR in cancer diagnosis and treatment prediction.

Main Methods:

• Immunohistochemical assessment of MMR proteins (MLH1, MSH2, MSH6, PMS2).
• Interpretation of MMR protein expression patterns in tumor tissues.
• Correlation of MMR status with clinical outcomes and diagnoses.

Main Results:

• dMMR is associated with increased tumor mutational burden and risk of various cancers.
• MMR protein deficiency predicts response to conventional chemotherapy and immunotherapy.
• MMR assessment is valuable for diagnosing Lynch syndrome and identifying sessile serrated lesions.

Conclusions:

• Immunohistochemical evaluation of MMR proteins is a key diagnostic and prognostic tool.
• Accurate MMR interpretation guides cancer screening, diagnosis, and therapeutic decisions.
• Understanding dMMR is essential for personalized cancer management and hereditary cancer risk assessment.